drugset / Trial / NCT07548957

A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions

NCT07548957 ↗

Phase 1 Not yet recruiting 44 enrolled Korea United Pharm. Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study was an open-label, randomized, single-dose, 2-sequence, 2-period, crossover study to evaluate the safety and pharmacokinetics of UI087 compared to coadministration of UIC202506, UIC202507 and UIC202508 in healthy adult volunteers under fasting conditions

Timeline

Start
2026-04
Primary completion
2026-08
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject UI087 Unknown — —
Comparator UIC202506 Unknown — —
Comparator UIC202507 Unknown — —
Comparator UIC202508 Unknown — —